Implementation of a rapid diagnostic assay package for cryptococcosis, histoplasmosis and tuberculosis in people living with HIV in Paraguay

Table 1 Baseline characteristics of the screened patients between August 2021 and June 2022

Characteristics	Total 491 (100%)		With OI 162 (33%)		Without-OI 329 (67%)		P value, x²
	n	%	n	%	n	%
Sex
Male	365	74	127	78	238	72	0.090
Female	126	26	35	22	91	28	0.090
Age
Median [IQR]	37	[30–46]	38	[31–44]	37	[30–46]	0.850
Residence
Rural	158	32	56	35	102	31	0.300
Urban	283	58	86	53	197	60
Unknown	50	10	20	12	30	9
Patient group*
A	68	14	7	4	61	19	< 0.0001
B	423	86	155	96	268	82	< 0.0001
New HIV diagnosis
Yes	217	44	68	42	149	45	0.275
No	274	56	94	58	180	55	0.275
CD4 + T-cell count
< 50	150	31	67	41	83	25	< 0.0001
50–99	119	24	47	29	72	22
100–199	112	23	31	19	81	25
200–350	74	15	15	9	59	18
>350	27	6	0	0.0	27	8
Unknown^±	9	2	2	1	7	2

OI = Opportunistic infection
*Group A: asymptomatic PLHIV with CD4 count < 350 cells/mm3, newly HIV diagnosed or re-engaged in care after being without ART for > 90 days. Group B: symptomatic PLHIV regardless of using ART or CD4 count
^±Patients without a recent CD4 cell count at the time of the opportunistic infections screening

ISSN: 1471-2334